Continuous Kidney Replacement Therapy and Outcomes of Severe Coronavirus Disease 2019 Treated With Extracorporeal Membrane Oxygenation
Therapeutic Apheresis and Dialysis · 2025
DOI: 10.1111/1744-9987.70071 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Therapeutic Apheresis and Dialysis, 2025. Verfasst von Yoshito Izutani und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Critical Care Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan. Hauptthemen laut MEDLINE: COVID-19, Extracorporeal Membrane Oxygenation, Continuous Renal Replacement Therapy, Acute Kidney Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Introduction
Although continuous kidney replacement therapy (CKRT) for acute kidney injury (AKI) management is common, its effect on the outcomes of patients treated with extracorporeal membrane oxygenation (ECMO) for severe coronavirus disease 2019 (COVID‐19) remains unclear. Therefore, we aimed to investigate the impact of CKRT on the outcomes of these patients.
Methods
Using a database of patients with severe COVID‐19 who required venovenous ECMO across three centers in Japan, we assessed demographics, clinical parameters, and in‐hospital mortality rates from January 2020 to December 2021.
Results
Data of 122 patients treated with ECMO for COVID‐19 were analyzed. Forty‐five patients required CKRT; the in‐hospital mortality rate was 28.7%. Multivariate analysis showed age and CKRT were independent risk factors for in‐hospital mortality. The in‐hospital mortality rate was significantly higher in the CKRT group.
Conclusion
CKRT was associated with significantly high in‐hospital mortality in patients treated with ECMO for severe COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency and Critical Care Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
- Department of Emergency and General Medicine, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
- Department of Critical Care and Emergency Center, Nanbu Medical Center and Children's Medical Center, Okinawa, Japan.
- Department of Emergency Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
- Department of Clinical Engineering Center, Fukuoka University Hospital, Fukuoka, Japan.
- Department of Emergency and Critical Care Medicine, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
ORCID-Profile: Yoshito Izutani, Yasumasa Kawano, Junta Noake, Jun Hamaguchi, Ryuichi Nakayama
Zitieren
APA
Izutani, Y., Kawano, Y., Fujita, A., Morimoto, S., Muranishi, K., Hoshino, K., Maruyama, J., Nakashio, M., Noake, J., Hatomoto, H., Yamasaki, S., Yamauchi, K., Hamaguchi, J., Bunya, N., Nakayama, R., Shimizu, K., & Nakamura, Y. (2025). Continuous Kidney Replacement Therapy and Outcomes of Severe Coronavirus Disease 2019 Treated With Extracorporeal Membrane Oxygenation. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.70071
Vancouver
Izutani Y, Kawano Y, Fujita A, Morimoto S, Muranishi K, Hoshino K, et al. Continuous Kidney Replacement Therapy and Outcomes of Severe Coronavirus Disease 2019 Treated With Extracorporeal Membrane Oxygenation. Therapeutic Apheresis and Dialysis. 2025. doi:10.1111/1744-9987.70071
BibTeX
@article{Izutani2025,
author = {Izutani, Yoshito and Kawano, Yasumasa and Fujita, Akihiro and Morimoto, Shinichi and Muranishi, Kentaro and Hoshino, Kota and Maruyama, Junichi and Nakashio, Maiko and Noake, Junta and Hatomoto, Hiroki and Yamasaki, Shintaro and Yamauchi, Kazuya and Hamaguchi, Jun and Bunya, Naofumi and Nakayama, Ryuichi and Shimizu, Keiki and Nakamura, Yoshihiko},
title = {Continuous Kidney Replacement Therapy and Outcomes of Severe Coronavirus Disease 2019 Treated With Extracorporeal Membrane Oxygenation},
journal = {Therapeutic Apheresis and Dialysis},
year = {2025},
doi = {10.1111/1744-9987.70071}
}
EUVIMED